Health Canada
Symbol of the Government of Canada

Common menu bar links

About Health Canada

Access to Information Requests Completed - November 2014

The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)

If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.

For the Month of November 2014
Request # Summary of Requests Status of Completed Request Number of Pages Disclosed
A-2011-00235 Information regarding ADVIL COLD AND SINUS PLUS, Drug Identification Number (DIN) 02248645. Disclosed in part 1,006
A-2011-01600 Documents relating to automobile brake products containing asbestos, with regards to the Risk Sciences International report, titled "Chrysotile Asbestos Exposure in Canada". (Sep 1, 2007 to Apr 30, 2010). Disclosed in part 597
A-2012-00790 Information regarding SALOFALK, Drug Identification Number (DIN) 02112787. Disclosed in part 422
A-2012-00801 Information regarding Clarus by Mylan Pharmaceuticals ULC. Disclosed in part 417
A-2012-01515 All documents related to the closure of Assisted Human Reproduction Canada. (Jan 1, 2012 to Feb 4 2013). Disclosed in part 34
A-2013-00937 Communications between the Therapeutic Products Directorate and the Minister's office related to the Special Access Program. (Jul 1, 2013 to Oct 31, 2013). Disclosed in part 6
A-2014-00027 Communications regarding Safety Code 6. (Mar 21, 2014 to Apr 8, 2014). Disclosed in part 443
A-2014-00374 Costs and cost estimates to the processing of licensed producer applications and inspections and oversight of licensed producers under the Marihuana for Medical Purposes Regulations. (Sep 1, 2013 to Jun 18, 2014). Disclosed in part 10
A-2014-00391 Information regarding: DIS2012-01 (the re-evaluation discussion document) published 30/11/12; the Pesticide Cost Recovery Consultation document published 14/3/14; and the presentations Proposed Changes to the Data Protection Submission Review Process and Stakeholder Feedback and Potential Changes to the Pesticide Data Protection Program made at the 28/3/14 Stakeholder Meeting on Data Protection Issues. Disclosed in part 136
A-2014-00441 Information regarding Povidone Iodine Solution, Natural Product Number (NPN) 00516341 by Professional Disposables International Ltd. Disclosed in part 23
A-2014-00442 Information regarding Acetone Alcohol Pad, Natural Product Number (NPN) 00534900 by Professional Disposables International Ltd. Disclosed in part 29
A-2014-00468 The number of medical marihuana prescriptions filed. (Apr 1, 2014 to Jul 14, 2014). Disclosed in part 177
A-2014-00488 Documents regarding the Human Resources Strategy/Plan; Annual Learning, Training and Development, Annual Reports on Learning, Annual Expenditures. (Apr 1, 2012 to Jul 17, 2014). Disclosed in part 183
A-2014-00489 Adverse Reaction Report (AER) for Onsior. Disclosed in part 5
A-2014-00513 Current copy of every memorandum of understanding, contract, or otherwise negotiated agreement that Non Insured Health Benefits has with those that collectively represent pharmacy providers in every province and territory in Canada. Disclosed in part 126
A-2014-00537 Adverse Reaction Report (AER) for Humira. Report numbers: 000591236, 000595520, 000595784. Disclosed in part 20
A-2014-00541 Document regarding applications for security clearance issued under the Marihuana for Medical Purposes Regulations. Disclosed in part 28
A-2014-00566 Reviewers notes for clinical section of the New Drug Submission for ANDRODERM. Disclosed in part 112
A-2014-00582 Information regarding HEPARTICHAUT TAB, Drug Identification Number (DIN) 00394874 by LES LABORATOIRES BIO-SANT╔ INC. Disclosed in part 4
A-2014-00583 Information regarding MEDICHOL, Drug Identification Number (DIN) 00134759 by MEDIC LABORATORY LT╔E. Disclosed in part 1
A-2014-00632 Adverse Reaction Report (AER). Report numbers: 000548814, 000585330. Disclosed in part 51
A-2014-00661 All contracts processed in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Task and Solutions Professional Services (TSPS) and for Task-Based Informatics Professional Services (TBIPS). (Apr 1, 2014 to Jul 31, 2014). Disclosed in part 532
A-2014-00695 Most recent package insert for the drug product: Morphine Sulfate INJ 10MG/ML USP. All disclosed 13
A-2014-00696 Most recent package insert for the Medical Devices: Cobas 4800 System, Cobas HPV AP. All disclosed 68
A-2014-00697 Adverse Reaction Report (AER) for Suprax. Report number: 000522285. Disclosed in part 1
A-2014-00698 Adverse Reaction Report (AER) for Suprax. Report number: 000538951. Disclosed in part 1
A-2014-00701 Adverse Reaction Report (AER) for Allegra. Report number: 000528855. Disclosed in part 23
A-2014-00702 Documents regarding all boil water advisories ever posted for the Alderville First Nation in Ontario. Disclosed in part 6
A-2014-00711 Adverse Reaction Report (AER) for Lasix. Report number: 000529335. Disclosed in part 12
A-2014-00729 List of all active centres conducting clinical trials. (Jan 1, 2009 to Dec 31, 2011). Disclosed in part 554
A-2014-00742 List (as of October 1, 2014) of all Marihuana Produces who have applied under the Marihuana for Medical Purposes Regulations that have yet to be approved or have been refused. Disclosed in part 14
A-2014-00746 Marihuana for Medical Purposes Regulations documents for applications, security and quality assurance regarding the license producers Tweed Inc. and Whistler Medical Marijuana Co. Disclosed in part 495
A-2014-00761 List of all applications out of the first 400 to become commercial producers of medical Marihuana who have passed at least the first level of review and are considered to be completely filled out. Disclosed in part 6
A-2014-00775 Communications between the 3 contractors and Public Works and Government Services Canada concerning the call for tenders HT360-123541; closing 2013-10-28. No records exist 0
A-2014-00796 Documents regarding genomics and/or the creation of Genome Canada. (Sep 1, 1998 to Nov 30, 1999). No records exist 0
A-2014-00816 Notification going out to Pharmaceutical Wholesalers concerning the marketability of one of Nutrimmune's products: Zinc Zap Spray and/or Zinc Zap Cream. No records exist 0
A-2014-00818 Complete list of all public opinion research and focus groups commissioned by Health Canada (Jan 1, 2007 and Oct 17, 2014). All disclosed 3
A-2014-00832 Adverse Reaction Report (AER) number: 000539190. Disclosed in part 1
A-2014-00836 Adverse Reaction Report (AER) for Nitrolingual Pumpspray. Report number: 000564279. Disclosed in part 1
A-2014-00838 Adverse Reaction Report (AER) for Diclectin. Report number: 000606899. Disclosed in part 2
A-2014-00844 Coroner's reports from the province of Manitoba related to First Nations maternal, neonatal, and infant deaths. (Jan 1, 2000 to Oct 24, 2014). No records exist 0
A-2014-00855 All briefing notes and memos prepared for the Minister of Health or assistant deputy ministers concerning Apotex. (Apr 1, 2014 to Oct 27, 2014). No records exist 0
A-2014-00856 All correspondence with the United States Food and Drug Administration and United States Department of Justice concerning the Shire Pharmaceuticals alleged improper marketing and promotion of several drugs. No records exist 0
A-2014-00879 All correspondence with the government of Liberia related to assistance from Canada on the Ebola outbreak. No records exist 0
A-2014-00890 Adverse Reaction Report (AER) for Eligard. Report number: 000575849. Disclosed in part 1
A-2014-00900 All briefing material related to the following entry in the 2013-14 Public Accounts of Canada: inappropriate use of government resources and unearned salary (1 case) (Amount of loss $141,423). No records exist 0
A-2014-00905 A listing of the Access to Information requests submitted to Health Canada. (Oct 1, 2014 to Oct 31, 2014). Disclosed in part 14
A-2014-00920 Adverse Reaction Report (AER) for Taxotere. Report number: 000589042. Disclosed in part 1
A-2014-00981 All available drafts and final copy of 2014 message event proposals related to the release of findings of Health Canada's wind turbine noise and health research. No records exist 0